{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:02:26Z","timestamp":1763154146026,"version":"3.37.3"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"suppl_7","license":[{"start":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:00:00Z","timestamp":1530489600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100010318","name":"University of Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010408","name":"Diagnostic Services Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010408","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Microbiology Laboratory\u2013Public Health Agency of Canada"},{"name":"NML"},{"DOI":"10.13039\/100011094","name":"PHAC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Canada Inc"},{"name":"Pfizer Canada Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1093\/jac\/dky156","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T06:40:04Z","timestamp":1524206404000},"page":"vii5-vii11","source":"Crossref","is-referenced-by-count":17,"title":["Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011\u201315"],"prefix":"10.1093","volume":"73","author":[{"given":"James A","family":"Karlowsky","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Room 543 - 745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9, Canada"},{"name":"Clinical Microbiology, Diagnostic Services Manitoba, MS673-820 Sherbrook Street, Winnipeg, Manitoba R3A 1R9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather J","family":"Adam","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Room 543 - 745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9, Canada"},{"name":"Clinical Microbiology, Diagnostic Services Manitoba, MS673-820 Sherbrook Street, Winnipeg, Manitoba R3A 1R9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa R","family":"Golden","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Room 543 - 745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie R","family":"Baxter","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Room 543 - 745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim A","family":"Nichol","sequence":"additional","affiliation":[{"name":"Clinical Microbiology, Diagnostic Services Manitoba, MS673-820 Sherbrook Street, Winnipeg, Manitoba R3A 1R9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Martin","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington St, Winnipeg, Manitoba R3E 3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Demczuk","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington St, Winnipeg, Manitoba R3E 3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R","family":"Mulvey","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Room 543 - 745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9, Canada"},{"name":"National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington St, Winnipeg, Manitoba R3E 3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew W","family":"Gilmour","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Room 543 - 745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9, Canada"},{"name":"National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington St, Winnipeg, Manitoba R3E 3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryl J","family":"Hoban","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Room 543 - 745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9, Canada"},{"name":"Clinical Microbiology, Diagnostic Services Manitoba, MS673-820 Sherbrook Street, Winnipeg, Manitoba R3A 1R9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George G","family":"Zhanel","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Room 543 - 745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Canadian Antimicrobial Resistance Alliance (CARA)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"key":"key\n\t\t\t\t20180702055750_dky156-B1","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2009.12.026","article-title":"The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007","volume":"28","author":"Bettinger","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180702055750_dky156-B2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/cid\/ciu497","article-title":"Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillance","volume":"59","author":"Kuster","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180702055750_dky156-B3","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1016\/j.vaccine.2009.03.063","article-title":"Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006","volume":"27","author":"Tyrrell","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180702055750_dky156-B4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180702055750_dky156-B5","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180702055750_dky156-B6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1089\/mdr.2011.0197","article-title":"Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine","volume":"18","author":"Adam","year":"2012","journal-title":"Microb Drug Resist"},{"key":"key\n\t\t\t\t20180702055750_dky156-B7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1139\/cjm-2013-0614","article-title":"Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal vaccine, 2010-2012","volume":"59","author":"Demczuk","year":"2013","journal-title":"Can J Microbiol"},{"year":"2014","author":"Public Health Agency of Canada. National Surveillance of Invasive Streptococcal Disease in Canada","key":"key\n\t\t\t\t20180702055750_dky156-B8"},{"year":"2016","author":"Centers for Disease Control and Prevention","key":"key\n\t\t\t\t20180702055750_dky156-B9"},{"year":"2016","author":"National Advisory Committee on Immunization","key":"key\n\t\t\t\t20180702055750_dky156-B10"},{"volume-title":"National Laboratory Surveillance of Invasive Streptococcal Disease in Canada\u2014Annual Summary 2014","author":"Streptococcus and STI Unit, Bacteriology and Enteric Diseases Program, National Microbiology Laboratory","key":"key\n\t\t\t\t20180702055750_dky156-B11"},{"volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically\u2014Tenth Edition: Approved Standard M07-A10","year":"2015","author":"Clinical and Laboratory Standards Institute","key":"key\n\t\t\t\t20180702055750_dky156-B12"},{"volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Seventh Edition. M100-S27","year":"2017","author":"Clinical and Laboratory Standards Institute","key":"key\n\t\t\t\t20180702055750_dky156-B13"},{"author":"Pfizer Inc","key":"key\n\t\t\t\t20180702055750_dky156-B14"},{"key":"key\n\t\t\t\t20180702055750_dky156-B15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkt332","article-title":"Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008","volume":"69","author":"Wierzbowski","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180702055750_dky156-B16","doi-asserted-by":"crossref","first-page":"vii12","DOI":"10.1093\/jac\/dky158","article-title":"Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15","volume":"73","author":"Adam","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180702055750_dky156-B17","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1128\/AAC.01260-07","article-title":"Increasing genetic relatedness of ciprofloxacin-resistant Streptococcus pneumoniae isolated in Canada from 1997 to 2005","volume":"52","author":"Nichol","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702055750_dky156-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkf500","article-title":"The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae","volume":"50","author":"Klugman","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180702055750_dky156-B19","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/JCM.39.7.2565-2571.2001","article-title":"Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network","volume":"39","author":"McGee","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180702055750_dky156-B20","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3201\/eid1010.040382","article-title":"Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain","volume":"10","author":"de la Campa","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180702055750_dky156-B21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JCM.40.1.68-74.2002","article-title":"Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada","volume":"40","author":"Greenberg","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180702055750_dky156-B22","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/jac\/dkv061","article-title":"Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13","volume":"70","author":"Golden","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180702055750_dky156-B23","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/AAC.40.9.2190","article-title":"Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae","volume":"40","author":"Simor","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702055750_dky156-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.27.1.1-5.1989","article-title":"Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics","volume":"27","author":"Jett\u00e9","year":"1989","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180702055750_dky156-B25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1155\/2001\/984958","article-title":"Reduced susceptibility to penicillin among pneumococci causing invasive infection in children\u2014Canada, 1991 to 1998","volume":"12","author":"Scheifele","year":"2001","journal-title":"Can J Infect Dis"},{"key":"key\n\t\t\t\t20180702055750_dky156-B26","first-page":"327","article-title":"Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995","volume":"158","author":"Lovgren","year":"1998","journal-title":"Can Med Assoc J"},{"key":"key\n\t\t\t\t20180702055750_dky156-B27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.diagmicrobio.2007.03.024","article-title":"Antimicrobial resistance among invasive isolates of Streptococcus pneumoniae collected across Canada","volume":"59","author":"Davidson","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180702055750_dky156-B28","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/AAC.47.6.1867-1874.2003","article-title":"Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian respiratory organism susceptibility study, 1997-2002","volume":"47","author":"Zhanel","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702055750_dky156-B29","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.42.7.1762","article-title":"Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)","volume":"42","author":"Pfaller","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702055750_dky156-B30","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1128\/AAC.00237-11","article-title":"Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"55","author":"Patel","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702055750_dky156-B31","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180702055750_dky156-B32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1128\/JCM.01778-16","article-title":"Emergence of multidrug-resistant pneumococcal serotype 35B among children in the United States","volume":"55","author":"Olarte","year":"2017","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/suppl_7\/vii5\/25112857\/dky156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T11:05:23Z","timestamp":1660993523000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/suppl_7\/vii5\/5047484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":32,"journal-issue":{"issue":"suppl_7","published-online":{"date-parts":[[2018,7,2]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky156","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,7,1]]}}}